VIVIMEDLAB Financial Statements

VIVIMEDLAB Quarterly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2018 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Revenue growth (19) 8.64 (2.50) 2.17
Op profit growth (47) 73.40 7.01 5.77
EBIT growth (53) 94.10 15.90 6.40
Net profit growth (64) 156 16.10 8.52
Profitability ratios (%)        
OPM 17.90 27.50 17.20 15.70
EBIT margin 13.90 24.10 13.50 11.30
Net profit margin 6.57 14.60 6.22 5.22
RoCE 8.68 21.40 11.60 10.20
RoNW 1.99 8.11 3.66 3.22
RoA 1.02 3.25 1.34 1.18
Per share ratios ()        
EPS 9.22 26.40 51.60 44.50
Dividend per share 0.40 0.40 -- --
Cash EPS 2.61 19.20 13.70 3.62
Book value per share 149 90.60 361 345
Valuation ratios        
P/E 7.71 4.03 1.61 1.65
P/CEPS 27.20 5.54 6.05 20.30
P/B 0.65 1.17 0.26 0.24
EV/EBIDTA 5.92 4.43 6.56 7.10
Payout (%)        
Dividend payout 4.24 1.53 -- --
Tax payout (11) (25) (16) (7.10)
Liquidity ratios        
Debtor days 73.20 65.70 88.90 89.60
Inventory days 158 123 127 116
Creditor days (71) (59) (58) (59)
Leverage ratios        
Interest coverage (2.10) (5.30) (2.20) (2)
Net debt / equity 0.59 1.30 1.57 1.76
Net debt / op. profit 3.42 2.37 3.96 4.54
Cost breakup ()        
Material costs (40) (37) (46) (47)
Employee costs (17) (13) (13) (13)
Other costs (25) (23) (23) (24)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Revenue 1,186 1,462 1,346 1,380
yoy growth (%) (19) 8.64 (2.50) 2.17
Raw materials (480) (536) (624) (646)
As % of sales 40.50 36.70 46.40 46.80
Employee costs (198) (190) (177) (184)
As % of sales 16.70 13 13.10 13.40
Other costs (296) (333) (313) (333)
As % of sales 25 22.80 23.20 24.10
Operating profit 212 403 232 217
OPM 17.90 27.50 17.20 15.70
Depreciation (56) (58) (61) (66)
Interest expense (79) (66) (82) (79)
Other income 9.61 8.09 10.80 5.87
Profit before tax 85.70 286 99.90 77.50
Taxes (9.60) (73) (16) (5.50)
Tax rate (11) (25) (16) (7.10)
Minorities and other 1.85 -- -- --
Adj. profit 77.90 214 83.70 72
Exceptional items -- -- -- --
Net profit 77.90 214 83.70 72.10
yoy growth (%) (64) 156 16.10 8.52
NPM 6.57 14.60 6.22 5.22
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Profit before tax 85.70 286 99.90 77.50
Depreciation (56) (58) (61) (66)
Tax paid (9.60) (73) (16) (5.50)
Working capital 743 398 356 19.10
Other operating items -- -- -- --
Operating cashflow 763 554 378 25
Capital expenditure 821 (252) 334 73.10
Free cash flow 1,584 302 712 98.10
Equity raised 1,328 709 851 887
Investments 2.70 2.01 2.45 2.46
Debt financing/disposal 867 593 504 200
Dividends paid 3.30 3.28 -- --
Other items -- -- -- --
Net in cash 3,785 1,609 2,069 1,188
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 16.60 16.50 16.50 16.20
Preference capital 325 325 325 --
Reserves 493 602 885 718
Net worth 835 944 1,226 734
Minority interest
Debt 943 955 824 1,011
Deferred tax liabilities (net) -- -- -- --
Total liabilities 1,777 1,899 2,063 1,745
Fixed assets 1,134 1,087 1,101 955
Intangible assets
Investments 85.70 2.51 2.70 2.71
Deferred tax asset (net) 13.70 6.79 7.86 6.46
Net working capital 493 707 852 725
Inventories 502 564 540 484
Inventory Days -- -- 166 121
Sundry debtors 249 356 275 200
Debtor days -- -- 84.80 50
Other current assets 174 218 368 358
Sundry creditors (227) (294) (202) (179)
Creditor days -- -- 62.20 44.60
Other current liabilities (206) (136) (129) (138)
Cash 50.50 95.30 99 55.50
Total assets 1,777 1,899 2,063 1,745
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021
Gross Sales 61.10 56.50 54.40 65.30 39
Excise Duty -- -- -- -- --
Net Sales 61.10 56.50 54.40 65.30 39
Other Operating Income -- -- -- -- --
Other Income 0.57 (0.40) 0.14 0.92 1.78
Total Income 61.70 56.20 54.50 66.20 40.80
Total Expenditure ** 62.20 63.80 64.90 54.50 55.30
PBIDT (0.50) (7.70) (10) 11.70 (15)
Interest 10.10 11.60 8.62 9.51 9.21
PBDT (11) (19) (19) 2.20 (24)
Depreciation 4.95 4.45 4.35 4.53 4.13
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- (0.40)
Deferred Tax 2.82 -- -- -- --
Reported Profit After Tax (18) (24) (23) (2.30) (27)
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest (18) (24) (23) (2.30) (27)
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item (18) (24) (23) (2.30) (27)
EPS (Unit Curr.) (2.20) (2.90) (2.80) (0.30) (3.30)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 16.60 16.60 16.60 16.60 16.60
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) (0.80) (14) (19) 17.90 (37)
PBDTM(%) (17) (34) (35) 3.37 (61)
PATM(%) (30) (42) (43) (3.60) (70)
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity